Marlboro Snus – Oral Cancer News

Monitoring Tobacco-Specific N-Nitrosamines and Nicotine in Novel Marlboro and Camel Smokeless Tobacco Products: Findings From Round 1 of the New Product Watch

Source: OxfordJournals.org Abstract Introduction: Information on chemical composition of the new oral “spitless” smokeless tobacco products is scarce, and it is not clear whether there is some variability as a function of purchase place or time due to either unintended or intended manufacturing variations or other conditions. Methods: We analyzed tobacco-specific N-nitrosamines (TSNA) and nicotine in Marlboro Snus, Camel Snus, and dissolvable Camel products Orbs, Sticks, and Strips that were purchased in various regions of the country during the summer of 2010. Results: A total of 117 samples were received from different states representing six regions of the country. Levels of unprotonated nicotine in Marlboro Snus and Camel Snus varied significantly by regions, with the differences between the highest and the lowest average regional levels being relatively small in Marlboro Snus (∼1.3-fold) and large in Camel Snus (∼3-fold). Some regional variations in TSNA levels were also observed. Overall, Camel Snus had significantly higher TSNA levels than Marlboro Snus, and Camel Strips had the lowest TSNA levels among all novel products analyzed here. The amount of unprotonated nicotine in the dissolvable Camel products was comparable to the levels found in Marlboro Snus. Conclusions: Our study demonstrates some regional variations in the levels of nicotine and TSNA in Marlboro and Camel novel smokeless tobacco products. Continued monitoring of this category of products is needed as the existing products are being test marketed and modified, and new products are being introduced. This information is particularly important given its relevance to Food and Drug [...]

Oral Cancer Foundation News Team - A2011-10-31T11:13:41-07:00October, 2011|Oral Cancer News|

On the Call: Altria Group CEO Michael Szymanczyk

Source: Business Week Richmond, VA Like other tobacco companies, Altria Group Inc. is focusing on cigarette alternatives such as cigars, snuff and chewing tobacco for sales growth as tax increases, smoking bans, health concerns and social stigma make the cigarette business tougher. The smokeless tobacco category is growing at about 7 percent a year, but still remains small compared with cigarettes. The parent company of the nation's biggest cigarette maker, Philip Morris USA, said Wednesday that volumes for its smokeless tobacco segment, which includes Copenhagen and Skoal, as well as Marlboro Snus, grew 16.4 percent in the third quarter and revenues excluding excise taxes increased about 11 percent to $363 million. In a conference call with analysts regarding Altria's third-quarter earnings, CEO Michael E. Szymanczyk talked about the company working with retailers to better align their shelf space with changes in the tobacco industry. QUESTION: Is the investment to help retailers reallocate their space and improve their display units for smokeless products meaningful to call out? RESPONSE: This is a category that has grown pretty substantially here over the last few years, but in retail stores, there hasn't been any significant movement in the space. At the same time, the cigarette category has declined in volume. And while inventories have come down in the cigarette business, the actual physical space devoted to cigarettes hasn't meaningfully changed. There's a good opportunity to play catch-up here. ... We're helping retailers redistribute their space so it's more consistent with their sales, and that [...]

Oral Cancer Foundation News Team - A2010-10-21T12:27:20-07:00October, 2010|Oral Cancer News|

Refurbished York plant churning out Marlboro Snus, a new smokeless tobacco product

Source: www.dailypress.com Author: Jon Cawley From outside the non-descript facility on Merrimac Trail nothing indicates it's home to Marlboro Snus, a spit-less, smokeless tobacco product that company officials say is gaining significant market traction. Inside, processed tobacco is finely ground, cooked, flavored, pouched and packaged by automated machinery in sanitary "clean rooms." High-speed robots can produce 150 Snus packages — each containing six individual pouches of tobacco — per minute, officials said during a recent plant tour. The York manufacturing center is the only place making Snus (pronounced snoose). The tobacco product has been in limited production since late 2007 but began nationwide distribution in March. That marks a big turnaround for the once-idle York County plant that underwent a $100 million renovation and expansion beginning in 2006 and now employs 17 salaried and 30 hourly workers along with 54 contractors. During renovations, Philip Morris USA gutted the facility, located across from Anheuser Busch's Williamsburg-area brewery. It had been closed for about three years since the company discontinued production of an electrically heated smoking device. The facility was expanded by 33,000 square feet to 139,000 square feet and fitted with high-tech machinery specific to making and packaging Snus. That construction was partly funded by a $650,000 state and county grant, said Ed Tucker, a director with the U.S. Smokeless Tobacco Manufacturing Co. Tucker said Snus and its packaging are discreet and designed to appeal to consumers as smoking restrictions continue to tighten. He said that because Snus is cooked instead [...]

Oral Cancer Foundation News Team - A2010-10-02T14:28:58-07:00October, 2010|Oral Cancer News|

Dissolvable tobacco products?

Source: www.wgnsradio.com Author: Scott Walker Dissolvable tobacco. What took the cigarette companies so long to come up with that? Made by R.J. Reynolds, the Camel Orb will debut in a few select markets next month before wider distribution. Rob Dunham with R.J. Reynolds says that the aspirin-sized tobacco product meets the needs of smokers because there’s no smoke, spit or litter to contend with. Meanwhile, the Altria Group, the owner of tobacco giant Philip Morris USA, is as pleased as punch with Marlboro Snus, which are smokeless pouches that take the place of chewing tobacco. While cigarette sales are dropping between two to three percent annually, Altria spokesman David Sutton says that smokeless products are booming sales-wise at a rate of six to eight percent each year. All of this news is disturbing to Greg Connolly of the Harvard School of Public Health. Connolly claims smokeless products are designed to enhance the social acceptability of tobacco and it’s apparently working, judging by the healthy sales. And while the Camel Orb and Marlboro Snus present fewer health risks, Connolly says they’re insidious because they keep people hooked and are appealing to youngsters.

Oral Cancer Foundation News Team - A2008-12-30T21:18:19-07:00December, 2008|Oral Cancer News|